Search results
Roche's (RHHBY) Ocrevus Subcutaneous Gets European Commission Nod
Zacks via Yahoo Finance· 4 hours agoRoche (RHHBY) obtains approval for the subcutaneous formulation of relapsing multiple sclerosis drug...
Roche (RHHBY), Ascidian Team Up for RNA Exon Editing Therapeutics
Zacks via Yahoo Finance· 6 days agoRoche (RHHBY) gets exclusive, target-specific rights to Ascidian's RNA exon editing technology for...
Will Roche Stock Rebound To Its 2022 Highs Of $50?
Forbes· 2 days agoIn contrast, its peer Bristol Myers Squibb stock (NYSE: BMY) saw a 48% decline over this period. RHHBY stock was trading at $42 in early June 2022, just...
Ascidian and Roche to develop RNA therapies for neurological diseases
Pharmaceutical Technology via Yahoo Finance· 7 days agoAscidian Therapeutics has entered a research partnership and licensing agreement with Roche to...
Roche launches B-cell lymphoma diagnostic assay in Europe
Medical Device Network via Yahoo Finance· 5 days agoRoche’s Ventana B-cell lymphoma diagnostic assay can detect and differentiate B-cell lymphomas and...
Target just announced its biggest sale of the season.
NBC Universal via AOL· 2 hours ago...dresses for the family 30% off bedding and bath, including Casaluna and Threshold 30% off select...
HighPoint Advisor Group LLC Buys New Holdings in Roche Holding AG (OTCMKTS:RHHBY)
ETF DAILY NEWS· 5 days agoHighPoint Advisor Group LLC purchased a new position in Roche Holding AG (OTCMKTS:RHHBY – Free Report) during the fourth quarter, according to its most recent disclosure with ...
Roche and Ascidian Therapeutics partner to develop RNA editing therapeutics
BioPharma-Reporter· 5 days agoAscidian Therapeutics and Roche have started a research collaboration and licensing agreement to...
US FDA approves Roche's drug for a chronic blood disorder
Reuters· 4 days ago, opens new tab drug for a chronic blood disorder, the Swiss drugmaker said. The drug crovalimab,...
Roche partners with Ascidian Therapeutics to develop gene therapies
Reuters· 7 days ago, opens new tab will team up with privately held biotech Ascidian Therapeutics to develop gene...